| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Pamrevlumab | FG-3019 | Phase 3 Clinical | Fibrogen Inc | Coronavirus Disease 2019 (COVID-19); Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glomerulosclerosis, Focal Segmental; Idiopathic Pulmonary Fibrosis; Liver Cirrhosis; Muscular Dystrophy, Duchenne; Pancreatic Neoplasms | Details |
| OLX-10010 | cp-asiCTGF; OLX-101A; OLX-10010; BMT-101; OLX-101 | Phase 2 Clinical | Olix Pharmaceuticals Inc | Cicatrix, Hypertrophic; Macular Degeneration; Pulmonary Fibrosis; Wet Macular Degeneration | Details |
| SHR-1906 | SHR-1906 | Phase 2 Clinical | Guangdong Hengrui Pharmaceutical Co Ltd | Idiopathic Pulmonary Fibrosis | Details |
| PRS-220 | PRS-220 | Phase 1 Clinical | Pieris Pharmaceuticals | Idiopathic Pulmonary Fibrosis | Details |
| LEM-S401 | LEM-S401; LEMS401 | Phase 1 Clinical | Lemonex Inc | Cicatrix | Details |
| English Name | Research Code | Highest Development Stage | Company | Earliest Brand Name | Earliest Approval Country | Earliest Indication | Earliest Approval Company | Earliest Approval Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Penicillamine | Approved | Valeant | Distamine, Pemine, Trisorcin, Cuprimine, Cupramine, Trolovol | United States | Arthritis, Rheumatoid; Hepatolenticular Degeneration; Cystinuria | Bausch Health Companies Inc | 1970-12-04 | Arthritis, Rheumatoid; Cystinuria; Heavy Metal Poisoning; Hepatolenticular Degeneration; Lead Poisoning | Details |